Literature DB >> 7828198

Ergotamine-induced headache can be sustained by sumatriptan daily intake.

T Catarci1, F Fiacco, C Argentino, G Sette, R Cerbo.   

Abstract

We describe the case report of a migraine sufferer who developed ergotamine-induced headache and subsequently replaced ergotamine with daily sumatriptan (100 mg p.o.). The features of the headache were unchanged except for the presence of superimposed migraine-like headaches that occurred every 24 h.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7828198     DOI: 10.1046/j.1468-2982.1994.1405374.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  7 in total

Review 1.  Medication overuse headache: a focus on analgesics, ergot alkaloids and triptans.

Authors:  Z Katsarava; H C Diener; V Limmroth
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Sumatriptan is not the only analgesic used inappropriately.

Authors:  P J Goadsby
Journal:  BMJ       Date:  1998-10-10

Review 3.  Drug overuse and rebound headache.

Authors:  Stephen D Silberstein; Dongmei Liu
Journal:  Curr Pain Headache Rep       Date:  2002-06

Review 4.  Analgesic rebound headache. How great is the problem and what can be done?

Authors:  S D Silberstein; W B Young
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

5.  The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache.

Authors:  R E Cull; W H Price; A Dunbar
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-05       Impact factor: 10.154

Review 6.  Analgesic/abortive overuse and misuse in chronic daily headache.

Authors:  H C Diener; Z Katasarva
Journal:  Curr Pain Headache Rep       Date:  2001-12

Review 7.  From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries.

Authors:  Marta Allena; Zaza Katsarava; Giuseppe Nappi
Journal:  J Headache Pain       Date:  2009-02-24       Impact factor: 7.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.